Gut microbiota dysbiosis and diabetic cardiomyopathy

doi:10.16352/j.issn.1001-6325.2026.01.0129

Abstract

Abstract: Dysregulation of gut microbiota and its metabolites contributes to diabetic cardiomyopathy (DCM) primarily through inflammation, oxidative stress, energy metabolism disturbances, insulin resistance, apoptosis and autophagy. Gut microbiota dysbiosis disrupts intestinal barrier function, triggering inflammation and oxidative stress, which exacerbate myocardial inflammation and damage. Additionally, gut microbiota modulates bile acid metabolism, influencing the activation of Takeda G protein-coupled receptor 5(TGR5), thereby affecting glucose and lipid metabolism as well as cardiac function. Metabolites such as trimethylamine N-oxide (TMAO) may activate inflammatory pathways and impair insulin signaling, reducing insulin sensitivity and exacerbating glucose metabolism disorders, further aggravating DCM. Targeting the gut microbiota composition and restoring the homeostasis of its metabolites may be potential strategy for the prevention and treatment of DCM.

Key words: diabetes, cardiomyopathy, gut microbiota, metabolic disorder, bile acids

CLC Number:

R587.2

SUN Qingyi, CHEN Guo, FU Xiao, SUN Haijian, LU Qingbo. Gut microbiota dysbiosis and diabetic cardiomyopathy[J]. Basic & Clinical Medicine, 2026, 46(1): 129-133.

References

[1]张静,王肖枭,周怡,等. 肠道菌群与疾病相关性的研究进展[J]. 基础医学与临床, 2020, 40: 243-247. doi: 10.16352/j.issn.1001-6325.2020.02.021.
[2]Li Z, Wan M, Wang M, et al. Modulation of gut microbiota on intestinal permeability: a novel strategy for treating gastrointestinal related diseases[J]. Int Immunopharmacol,, 2024, 137: 112416. doi: 10.1016/j.intimp.2024.112416.
[3]Yang G, Zhang X. TMAO promotes apoptosis and oxida-tive stress of pancreatic acinar cells by mediating IRE1α-XBP-1 pathway[J]. Saudi J Gastroenterol, 2021, 27: 361-369. doi: 10.4103/sjg.sjg_12_21.
[4]Song H, Xue H, Zhang Z, et al. Amelioration of type 2 diabetes using four strains of lactobacillus probiotics: effects on gut microbiota reconstitution-mediated regulation of glucose homeostasis, inflammation, and oxidative stress in mice[J]. J Agric Food Chem, 2023, 71: 20801-20814. doi: 10.1021/acs.jafc.3c04665.
[5]Perry RJ, Peng L, Barry NA, et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome[J]. Nature, 2016, 534: 213-217. doi: 10.1038/nature18309.
[6]Zheng H, Zhang X, Li C, et al. BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21[J]. Microbiome, 2024, 12: 157. doi: 10.1186/s40168-024-01872-3.
[7]Xu J, Núñez G. The NLRP3 inflammasome: activation and regulation[J]. Trends Biochem Sci, 2023, 48: 331-344. doi: 10.1016/j.tibs.2022.10.002.
[8]Ramachandran R, Manan A, Kim J, et al. NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders[J]. Exp Mol Med, 2024, 56: 1488-1500. doi: 10.1038/s12276-024-01261-8.
[9]Abudoureyimu A, Aihaiti A, Abudoujilili N, et al. Diabetic cardiomyopathy uncovered: transcriptomics, NLRP3, and carvedilol mechanisms[J]. J Diabetes Res, 2024, 2024: 9378405. doi: 10.1155/2024/9378405.
[10]Jia G, Habibi J, DeMarco VG, et al. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females[J]. Hypertension (dallas, Tex.: 1979), 2015, 66: 1159-1167. doi: 10.1161/HYPERTENSIONAHA.115.06015.
[11]Chen L, Zhang L, Hua H, et al. Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis[J]. Immun Inflamm Dis, 2024, 12: e1356. doi: 10.1002/iid3.1356.
[12]Sun X, Jiao X, Ma Y, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome[J]. Biochem Biophys Res Commun, 2016, 481: 63-70. doi: 10.1016/j.bbrc.2016.11.017.
[13]Mishra SP, Wang B, Jain S, et al. A mechanism by which gut microbiota elevates permeability and inflamma-tion in obese/diabetic mice and human gut[J]. Gut, 2023, 72: 1848-1865. doi: 10.1136/gutjnl-2022-327365.
[14]Cao F, Jin L, Gao Y, et al. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis[J]. Nat Nanotechnol, 2023, 18: 617-627. doi: 10.1038/s41565-023-01346-x.
[15]Wu Y, Zhang C, Teng Y, et al. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles[J]. Mil Med Res, 2022, 9: 46. doi: 10.1186/s40779-022-00404-0.
[16]崔桂丽,王瑞玲,马琴,等. 自噬在高糖高脂引起心肌细胞系H9C2凋亡中的影响[J]. 基础医学与临床, 2017, 37: 1699-1705. doi: 10.16352/j.issn.1001-6325.2017.12.007.
[17]Nie N, Bai C, Song S, et al. Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways[J]. Mol Cell Biochem, 2020, 464: 83-91. doi: 10.1007/s11010-019-03651-3.
[18]Liu Y, Zhou Q, Ye F, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization[J]. Neoplasia(New York, N.y.), 2023, 43: 100928. doi: 10.1016/j.neo.2023.100928.
[19]Shoeib HM, Keshk WA, Al-Ghazaly GM, et al. Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients[J]. Gene, 2023, 851: 146978. doi: 10.1016/j.gene.2022.146978.
[20]Liu C, Yao Q, Hu T, et al. Cathepsin B deteriorates diabetic cardiomyopathy induced by streptozotocin via promoting NLRP3-mediated pyroptosis[J]. Mol Ther Nucleic Acids, 2022, 30: 198-207. doi: 10.1016/j.omtn.2022.09.019.
[21]Cohen H, Baram N, Edry-Botzer L, et al. Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome[J]. Emerg Microbes Infect, 2020, 9: 278-290. doi: 10.1080/22221751.2020.1720526.
[22]Liu D, Li C, Cao T, et al. Bifidobacterium longum K5 prevents enterohaemorrhagic Escherichia coli O157:H7 infection in mice through the modulation of the gut microbiota[J]. Nutrients, 2024, 16: 1164. doi: 10.3390/nu16081164.
[23]Liu H, Gu F, Zhu C, et al. Epithelial heat shock proteins mediate the protective effects of limosilactobacillus reuteri in dextran sulfate sodium-induced colitis[J]. Front Immunol, 2022, 13: 865982. doi: 10.3389/fimmu.2022.865982.
[24]Bastos RMC, Simplício-Filho A, Sávio-Silva C, et al. Fecal microbiota transplant in a pre-clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease[J]. Front Immunol, 2022, 23: 3842. doi: 10.3390/ijms23073842.
[25]Zhu J, Bao Z, Hu Z, et al. Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites[J]. Nutr Diabetes, 2024, 14: 10. doi: 10.1038/s41387-024-00268-4.
[26]Wu H, Zhang P, Zhou J, et al. Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy[J]. Am J Physiol Cell Physiol, 2024, 326: C724-C741. doi: 10.1152/ajpcell.00565.2023.